ArticleInvestigational new drugs2025

Ceralasertib, an ATR kinase inhibitor, as monotherapy in Japanese patients with advanced solid malignancies: Results from a phase 1 study.

Yasutoshi Kuboki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.